Mesenchymal Stromal Cell Delivery via an Ex Vivo Bioreactor Preclinical Test System Attenuates Clot Formation for Intravascular Application
B. O'Rourke, S. Nguyen, A. Tilles, J. Bynum, A. Cap, B. Parekkadan, R. Barcia
This study shows that using a bioreactor to isolate mesenchymal stromal cells (MSCs) delays clot formation compared to free MSCs, suggesting improved safety for systemic administration.
bioRxiv · Nov 20, 2020Bioengineering